Task: Answer the multiple choice question.
Question: Which drug exhibits a 18.871% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
(a) COc1cccc(/C=N/NC(=O)c2cccc([N+](=O)[O-])c2)c1OS(=O)(=O)c1ccccc1
(b) Cc1nn(Cc2noc(C(=O)NC3CCC(C)CC3)n2)c(C)c1Br
Answer: b. Cc1nn(Cc2noc(C(=O)NC3CCC(C)CC3)n2)c(C)c1Br
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nn(Cc2noc(C(=O)NC3CCC(C)CC3)n2)c(C)c1Br
Cc1nn(Cc2noc(C(=O)NC3CCC(C)CC3)n2)c(C)c1Br
3-[(4-bromo-3,5-dimethylpyrazol-1-yl)methyl]-N-(4-methylcyclohexyl)-1,2,4-oxadiazole-5-carboxamide